Patent · 2024 · pending
Treatment of PLOD2 Related Diseases and Disorders
siRNA and antisense oligonucleotides targeting PLOD2, for conditions associated with PLOD2.
- Filings
- 1
- Status
- Pending
- First priority
- May 15, 2024
Patent · 2024 · pending
siRNA and antisense oligonucleotides targeting PLOD2, for conditions associated with PLOD2.